Rice Biotech Launch Pad invents 'living pharmacy' designed to produce therapeutics inside the body

A Houston-based announcement said a durable implant designed to deliver biologic therapies for a full year is planned to enter clinical testing in 2027. The platform is positioned as a new therapeutic approach with multiple potential applications and could address access constraints created by the high cost of biologic medicines, although no clinical efficacy, regulatory, or financial data were disclosed.